This new generation analyzer Microsemi CRP LC-767G is more compact and proposes enhanced software and network connectivity providing higher memory, usability plus a new ratio: Granulocytes-to-Lymphocytes Ratio (GLR).

The Microsemi CRP LC-767G provides information of great clinical value enabling quicker and more accurate medical decisions at the Point of Care to ultimately reduce hospitalization times and patient costs.

Its powerful and accurate CRP analysis allows the screening of patient samples to quantify the presence of inflammation caused by bacterial, viral (e.g. COVID-19), parasites infections (e.g. Malaria) and other treatable inflammatory diseases.

Measurement is possible immediately after blood sample collection from capillary sample, making this analyzer the ideal choice for emergency testing situations.

Simultaneous access to Lymphocytes, GLR and CRP provided on this analyzer is very helpful for COVID-19 patient screening, monitoring and triage.

Furthermore, its micro-sampling capabilities are ideal for pediatric blood analysis, at the Point of Care requiring just 10µL for CBC and 18 µL for CBC+CRP, and can be used with capillary, as well as venous blood samples.

The Microsemi CRP is easy to use and does not require specialist staff. Comprehensive and efficient on-board software with color touchscreen and easy to access patient and control results are features of the Microsemi CRP. Its design characteristics have created an environmentally friendly model that is incredibly compact, lightweight and quiet.  

*This product is not in any way affiliated with MICROSEMI Corporation.